Alpine Immune Sciences Inc

NASDAQ:ALPN   3:59:53 PM EDT
9.04
+0.53 (+6.23%)
Earnings Announcements

Alpine Immune Reports Q4 And Full Year 2021 Financial Results

Published: 03/17/2022 20:19 GMT
Alpine Immune Sciences Inc (ALPN) - Alpine Immune Sciences Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results.
Alpine Immune Sciences Inc - Qtrly Loss per Share $0.52.
Revenue is expected to be $10.04 Million
Adjusted EPS is expected to be -$0.38

Next Quarter Revenue Guidance is expected to be $18.71 Million
Next Quarter EPS Guidance is expected to be -$0.11

More details on our Analysts Page.